AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 47 filers reported holding AMPIO PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $8,000 | -27.3% | 19,508 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $11,000 | +37.5% | 19,508 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $8,000 | -20.0% | 19,508 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $10,000 | -76.7% | 19,508 | 0.0% | 0.00% | -75.0% |
Q2 2018 | $43,000 | -34.8% | 19,508 | 0.0% | 0.00% | -33.3% |
Q1 2018 | $66,000 | -16.5% | 19,508 | 0.0% | 0.01% | -14.3% |
Q4 2017 | $79,000 | +558.3% | 19,508 | 0.0% | 0.01% | +600.0% |
Q3 2017 | $12,000 | +20.0% | 19,508 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $10,000 | -37.5% | 19,508 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $16,000 | -11.1% | 19,508 | 0.0% | 0.00% | -50.0% |
Q4 2016 | $18,000 | +28.6% | 19,508 | 0.0% | 0.00% | +100.0% |
Q3 2016 | $14,000 | -44.0% | 19,508 | 0.0% | 0.00% | -50.0% |
Q2 2016 | $25,000 | -43.2% | 19,508 | 0.0% | 0.00% | -50.0% |
Q1 2016 | $44,000 | -35.3% | 19,508 | 0.0% | 0.00% | -33.3% |
Q4 2015 | $68,000 | +21.4% | 19,508 | 0.0% | 0.01% | 0.0% |
Q3 2015 | $56,000 | +21.7% | 19,508 | 0.0% | 0.01% | +50.0% |
Q2 2015 | $46,000 | -68.7% | 19,508 | 0.0% | 0.00% | -66.7% |
Q1 2015 | $147,000 | +119.4% | 19,508 | 0.0% | 0.01% | +100.0% |
Q4 2014 | $67,000 | – | 19,508 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Empery Asset Management, LP | 4,262,409 | $2,430,000 | 5.07% |
CVI Holdings, LLC | 5,171,896 | $2,948,000 | 0.20% |
PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $534,000 | 0.18% |
CVA Family Office, LLC | 1,137,920 | $649,000 | 0.16% |
ACT CAPITAL MANAGEMENT, LLC | 291,500 | $166,000 | 0.12% |
Cypress Capital Management LLC (WY) | 196,775 | $112,000 | 0.09% |
Willis Investment Counsel | 2,181,840 | $1,244,000 | 0.06% |
NTB Financial Corp | 146,100 | $83,000 | 0.06% |
Helen Stephens Group, LLC | 117,222 | $67,000 | 0.05% |
SRS Capital Advisors, Inc. | 629,172 | $359,000 | 0.05% |